© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Intelence

Insuring My Future By Starting HIV Medication

The process toward a creating a healthier lifestyle and discovering my genotype.

Intelence

Many People With HIV Could Switch to Newer, Safer Regimens

A majority of people taking antiretrovirals to treat HIV could switch to newer regimens with improved side effect profiles.

HIV Meds Much Cheaper Globally, Unless They’re Newer Drugs

Global prices for first- and second-line HIV therapies have plummeted, but newer therapies are still hugely expensive.

FDA Updates the Labels of Intelence (Etravirine) and Prezista (Darunavir)

The U.S. Food and Drug Administration has approved changes to the labels for the antiretrovirals (ARVs) Intelence (etravirine) and Prezista (d...

Second-Generation Non-Nuke Approved for Children 6 and Older

Children between 6 and 17 years old may now use Intelence, a non-nucleoside reverse transcriptase inhibitor (NNRTI) that has shown to be...

Isentress, Intelence, Prezista Regimen Goes the Distance for HIV Treatment Veterans

A drug regimen containing Isentress (raltegravir), Intelence (etravirine) and Norvir (ritonavir)–boosted Prezista (darunavir)...

HIV Meds Played Out? Deal Again.

If you have lived with HIV for a long time and have exhausted various med combos in the past, there are still options.

HIV Drug Development Stalls

Companies that develop HIV drugs are at a standstill in bringing new medicines to market, Bloomberg reports.

After 2 Years, Drug Regimen Works Well Among Treatment-Experienced

A drug regimen containing Isentress (raltegravir), Intelence (etravirine) and Norvir (ritonavir)?boosted Prezista (darunavir) continues to wor...

New One Pill, Twice Daily Dosing for HIV Non-Nuke Intelence

Good news for Intelence (etravirine) users: Instead of two 100 milligram (mg) tablets twice a day, the recent approval of a 200 mg tablet will...

Switch From Efavirenz to Intelence Improves Side Effects in Some

People on a regimen containing efavirenz (found in Sustiva and Atripla) who have neurological side effects or abnormal cholesterol or triglyce...

Johnson & Johnson Expands Work in Infectious Diseases

Johnson & Johnson plans to expand its work in infectious diseases such as HIV, hepatitis C and the flu.

Switch From Sustiva to Intelence Reduces Central Nervous System Side Effects

People with central nervous system (CNS) side effects, who switched from Sustiva (efavirenz) plus two nucleoside reverse transcriptase inhibit...

A Slower Response to HIV Treatment Is Just as Good as a Fast Response

People whose HIV levels drop more slowly after starting antiretroviral (ARV) therapy do just as well over two years as people whose virus drop...

Medicine Chest

HIV drug news
Advertisement